TNF-α was demonstrated to be responsible for acute lung injury in SIRS after CPB leading to increased MV times, ICU LOS, and HLOS [21] These specific biomarkers are expensive and are not readily available, especially to patients in the developing world. This evidence concerns the gene TNF and systemic inflammatory response syndrome.